関連する実験動画

Updated: Sep 10, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

症例報告: 2 つの異なるEGFR変異を有する双方向同期原発非小細胞肺がん患者

Thanh-Dung Quach1,2, Kien Hung Do3, Dinh Tung Nguyen1,2

  • 1Oncology Center, Vinmec Times City International Hospital, Vinmec Healthcare System, Hanoi, Vietnam.

Cancer reports (Hoboken, N.J.)
|August 26, 2025
PubMed
まとめ

このケーススタディは,二つの異なる表皮成長因子受容体 (EGFR) 変異を有する同期双方の非小細胞肺がん (NSCLC) の希少な事例を詳細に説明しています. 効果的なNSCLC治療戦略には,包括的な分子プロファイリングが不可欠です.

キーワード:
EGFR変異アファチニブ非小細胞肺がん

さらに関連する動画

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.7K

関連する概念動画

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K